Glypican-3 (GPC3)
Price range: $295.00 through $1,073.00
Description
Product Description
Glypican-3 (GPC3), a member of the glypican family of glycosyl phosphatidylinositol-anchored cell-surface heparin sulfate proteoglycans, plays an important role in cell growth and differentiation.15 Using the 1G12 monoclonal antibody, GPC3 has been identified as a useful tumor marker for the diagnosis of Hepatocellular Carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilms’ tumor.15-18
Specifications
Specifications
| Weight | N/A |
|---|---|
| Dimensions | N/A |
| Intended Use | |
| Species Reactivity | |
| Source | |
| Clone | |
| Isotype | |
| Antigen | |
| Localization | |
| Positive Control |
Datasheets & SDS
| Download CE Marked IVD Datasheet |
| Download IVD Datasheet Without CE Mark |
| Download SDS Sheet |
Browse more documents for this product (IFUs, datasheets, translations, SDS, and more).
International
References
1. Kandil DH, et al., Glypican-3 A novel diagnostic marker for hepatocellular carcinoma and more. Adv Anat Pathol. 16(2): 125-9., 2009.
2. Shirakawa H, et al., Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. Int. J. Oncol., 34(3): 649-56, 2009.
3. Wang XY, et al., Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinoma. Human Pathol., 37(11): 1435 -41. 2006.
4. Libbrecht L, et al, Glypican-3 expression distinguishes small hepatocellular carcinoma from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am. J. Surg. Pathol., 30(11): 1405-11. 2006.
5. Center for Disease Control Manual. Guide: Safety Management, NO. CDC-22, Atlanta, GA. April 30, 1976 “Decontamination of Laboratory Sink Drains to Remove Azide Salts.”
6. National Committee for Clinical Laboratory Standards (NCCLS). Protection of laboratory workers from infectious diseases transmitted by blood and tissue; proposed guideline. Villanova, PA 1991;7(9). Order code M29-P.
